Can free DNA be detected in sputum of lung cancer patients?

Lung Cancer

Volumn 61, Issue 3, 2008, Pages 385-390

  van der Drift, M A ^a   Prinsen, C F M ^b   Hol, B E A ^b   Bolijn, A S ^b   Jeunink, M A F ^b   Dekhuijzen, P N R ^a   Thunnissen, F B J M ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Cytology; Free DNA; Inflammation; Lung cancer; Methylation; Sputum

Indexed keywords

BETA GLOBIN; DNA; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA HYPERMETHYLATION; DNA METHYLATION; FEMALE; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; PNEUMONIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPUTUM ANALYSIS;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENES, RAS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM; STATISTICS, NONPARAMETRIC;

EID: 50849129443     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.01.007     Document Type: Article

References (34)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Fontana R.S., Sanderson D.R., Woolner L.B., Taylor W.F., Miller W.E., and Muhm J.R. Lung cancer screening: the Mayo program. J Occup Med 28 (1986) 746-750
3. Frost J.K., Ball Jr. W.C., Levin M.L., Tockman M.S., Baker R.R., Carter D., et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis 130 (1984) 549-554
4. Flehinger B.J., Melamed M.R., Zaman M.B., Heelan R.T., Perchick W.B., and Martini N. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis 130 (1984) 555-560
5. Thunnissen F.B. Sputum examination for early detection of lung cancer. J Clin Pathol 56 (2003) 805-810
6. Johnston W.W., and Bossen E.H. Ten years of respiratory cytopathology at Duke University Medical Center. II. The cytopathologic diagnosis of lung cancer during the years 1970-1974, with a comparison between cytopathology and histopathology in the typing of lung cancer. Acta Cytol 25 (1981) 499-505
7. Mehta A.C., Marty J.J., and Lee F.Y. Sputum cytology. Clin Chest Med 14 (1993) 69-85
8. Schreiber G., and McCrory D.C. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest 123 (2003) 115S-128S
9. Bocking A., Biesterfeld S., Chatelain R., Gien-Gerlach G., and Esser E. Diagnosis of bronchial carcinoma on sections of paraffin-embedded sputum. Sensitivity and specificity of an alternative to routine cytology. Acta Cytol 36 (1992) 37-47
10. Risse E.K., van't Hof M.A., Laurini R.N., and Vooijs P.G. Sputum cytology by the Saccomanno method in diagnosing lung malignancy. Diagn Cytopathol 1 (1985) 286-291
11. Risse E.K., van't Hof M.A., and Vooijs G.P. Relationship between patient characteristics and the sputum cytologic diagnosis of lung cancer. Acta Cytol 31 (1987) 159-165
12. Sing A., Freudenberg N., Kortsik C., Wertzel H., Klosa B., and Hasse J. Comparison of the sensitivity of sputum and brush cytology in the diagnosis of lung carcinomas. Acta Cytol 41 (1997) 399-408
13. Steinman C.R. Free DNA in serum and plasma from normal adults. J Clin Invest 56 (1975) 512-515
14. Shapiro B., Chakrabarty M., Cohn E.M., and Leon S.A. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer 51 (1983) 2116-2120
15. Anker P., Mulcahy H., Chen X.Q., and Stroun M. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev 18 (1999) 65-73
16. Sozzi G., Conte D., Leon M., Ciricione R., Roz L., Ratcliffe C., et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 21 (2003) 3902-3908
17. Sozzi G., Conte D., Mariani L., Lo Vullo S., Roz L., Lombardo C., et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 61 (2001) 4675-4678
18. Gautschi O., Bigosch C., Huegli B., Jermann M., Marx A., Chasse E., et al. Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol 22 (2004) 4157-4164
19. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2006. Available from: http://www.goldcopd.org.
20. Kennedy T.C., Proudfoot S.P., Piantadosi S., Wu L., Saccomanno G., Petty T.L., et al. Efficacy of two sputum collection techniques in patients with air flow obstruction. Acta Cytol 43 (1999) 630-636
21. Field J.K., Brambilla C., Caporaso N., Flahault A., Henschke C., Herman J., et al. Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations. Int J Oncol 21 (2002) 369-373
22. Thunnissen F.B., Peterse J.L., Buchholtz R., Van der Beek J.M., and Bosman F.T. Polyploidy in pleomorphic adenomas with cytological atypia. Cytopathology 3 (1992) 101-109
23. Saccomanno G., Archer V.E., Auerbach O., Saunders R.P., and Brennan L.M. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 33 (1974) 256-270
24. Travis W.D., Brambilla E., Muller-Hermlink H.K., and Harris C.C. World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart (2004)
25. Klaassen C.H., Jeunink M.A., Prinsen C.F., Ruers T.J., Tan A.C., Strobbe L.J., et al. Quantification of human DNA in feces as a diagnostic test for the presence of colorectal cancer. Clin Chem 49 (2003) 1185-1187
26. Shivapurkar N., Stastny V., Suzuki M., Wistuba I.I., Li L., Zheng Y., et al. Application of a methylation gene panel by quantitative PCR for lung cancers. Cancer Lett 25 4 (2006)
27. Sasaki M., Anast J., Bassett W., Kawakami T., Sakuragi N., and Dahiya R. Bisulfite conversion-specific and methylation-specific PCR: a sensitive technique for accurate evaluation of CpG methylation. Biochem Biophys Res Commun 309 (2003) 305-309
28. Cirincione R., Lintas C., Conte D., Mariani L., Roz L., Vignola A.M., et al. Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study. Int J Cancer 118 (2006) 1248-1253
29. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest 111 (1997) 1710-1717
30. Honorio S., Agathanggelou A., Schuermann M., Pankow W., Viacava P., Maher E.R., et al. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients. Oncogene 22 (2003) 147-150
31. van der Drift M.A., van der Wilt G.J., Thunnissen F.B., and Janssen J.P. A prospective study of the timing and cost-effectiveness of bronchial washing during bronchoscopy for pulmonary malignant tumors. Chest 128 (2005) 394-400
32. Roby T.J., Swan G.E., Sorensen K.W., Hubbard G.A., and Schumann G.B. Discriminant analysis of lower respiratory tract components associated with cigarette smoking, based on quantitative sputum cytology. Acta Cytol 34 (1990) 147-154
33. Lopez-Encuentra A. Comorbidity in operable lung cancer: a multicenter descriptive study on 2992 patients. Lung Cancer 35 (2002) 263-269
34. Ronchi M.C., Piragino C., Rosi E., Amendola M., Duranti R., and Scano G. Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax 51 (1996) 1000-1004